Current epigenetic studies have shown that ACE2 hypomethylation in the nasal epithelium can lead to increased SARS-CoV-2 infectivity and COVID-19 severity via a greater abundance of ACE2 receptors (7, 8). Here, ACE2 is linked to COVID-19.